ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics
GET POWR RATINGS... FREE!
ANIP POWR Grades
- Growth is the dimension where ANIP ranks best; there it ranks ahead of 96.03% of US stocks.
- The strongest trend for ANIP is in Momentum, which has been heading down over the past 31 weeks.
- ANIP's current lowest rank is in the Momentum metric (where it is better than 11.83% of US stocks).
ANIP Stock Summary
- Of note is the ratio of Ani Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; 28.38% of US stocks have a lower such ratio.
- Over the past twelve months, ANIP has reported earnings growth of -252.97%, putting it ahead of only 8.37% of US stocks in our set.
- In terms of volatility of its share price, ANIP is more volatile than only 13.96% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Ani Pharmaceuticals Inc, a group of peers worth examining would be ESTE, HAYN, MBII, STIM, and PWFL.
- Visit ANIP's SEC page to see the company's official filings. To visit the company's web site, go to www.anipharmaceuticals.com.
ANIP Price Target
For more insight on analysts targets of ANIP, see our ANIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $38.33 | Average Broker Recommendation | 1.5 (Moderate Buy) |
ANIP Stock Price Chart Interactive Chart >
ANIP Price/Volume Stats
| Current price | $33.09 | 52-week high | $40.00 |
| Prev. close | $33.62 | 52-week low | $23.55 |
| Day low | $33.09 | Volume | 273 |
| Day high | $33.46 | Avg. volume | 56,975 |
| 50-day MA | $34.26 | Dividend yield | N/A |
| 200-day MA | $30.98 | Market Cap | 409.16M |
ANI Pharmaceuticals, Inc. (ANIP) Company Bio
ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.
Latest ANIP News From Around the Web
Below are the latest news stories about Ani Pharmaceuticals Inc that investors may wish to consider to help them evaluate ANIP as an investment opportunity.
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021BAUDETTE, Minn., Jun 15, 2021--ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows: |
ANI Pharmaceuticals Reports First Quarter 2021 Results - BioSpaceANI Pharmaceuticals Reports First Quarter 2021 Results BioSpace |
ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of StockholdersANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time. |
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: Date: Friday, June 4, 2021 Time: 10:00 a.m. ET |
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by New York State Teachers Retirement SystemNew York State Teachers Retirement System trimmed its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) by 2.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,180 shares of the specialty pharmaceutical companys stock after selling 700 shares during the period. New [] |
ANIP Price Returns
| 1-mo | -6.47% |
| 3-mo | 6.50% |
| 6-mo | 18.18% |
| 1-year | 8.24% |
| 3-year | -51.40% |
| 5-year | -41.19% |
| YTD | 13.95% |
| 2020 | -52.91% |
| 2019 | 36.98% |
| 2018 | -30.15% |
| 2017 | 6.32% |
| 2016 | 34.32% |
Continue Researching ANIP
Want to do more research on Ani Pharmaceuticals Inc's stock and its price? Try the links below:Ani Pharmaceuticals Inc (ANIP) Stock Price | Nasdaq
Ani Pharmaceuticals Inc (ANIP) Stock Quote, History and News - Yahoo Finance
Ani Pharmaceuticals Inc (ANIP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...